Free-text search
Articles per year:
Content Types
-
Gothenburg researcher aims to launch CAR-T trial for childhood brain tumours
A year ago, Lars Karlsson was named Childhood Cancer Researcher of the Year for his work in the US on CAR-T therapy for children with the aggressive brain tumour diffuse intrinsic pontine glioma, or DIPG. The next step is to work on launching a clinical trial in Gothenburg for children in Sweden.
-
European biopharma leaders are optimistic on funding issue, but it keeps them up at night
The European biotech leaders see an increase in the acces to capital over the next year, but there's still worries on the matter.
-
Björn Arvidsson: “We skip the most important step after research”
In Sweden, we are proud of our research – and rightly so. We invest substantial resources and have internationally recognised strengths in life science. But when we debate how research should be translated into real-world value, we often make a strange leap: straight from research to implementation in healthcare. Björn Arvidsson explores the missing step in this column.
-
Nobel laureate’s CRISPR biotech shuts down as funding runs out
Caribou Biosciences was one of the early companies to embrace CRISPR gene-editing technology. Now, the biotech is being forced to halt development of its cancer therapies, despite having a candidate ready for phase III.
-
How GLP-1 drugs are changing what we buy at the supermarket
In both Sweden and Denmark, grocery industry organisations are predicting billion-krona sales losses as the use of weight-loss drugs increases. So far, however, major supermarket chains say they have seen little sign of an impact.
-
EU Discusses Suspected Pneumonic Plague Case in Russia
EU member states discussed the suspected case of pneumonic plague in Russia after the issue was added Wednesday to the agenda of the Health Security Committee. Meanwhile, the World Health Organization (WHO) has requested additional information from Russia regarding the incident.
-
WHO puts lifestyle changes before weight-loss drugs for children
The World Health Organization (WHO) has published its first global guidelines for tackling obesity among children and adolescents. The recommendations include dietary changes, increased physical activity and behavioural support.
-
Mirror-image molecule discoveries win Nobel Prize in Chemistry
The 2026 Nobel Prize in Chemistry is awarded to French chemist Henri B. Kagan and Japanese chemist Kenso Soai for discoveries that explain how chemical reactions can produce molecules with only one of two possible mirror-image forms.
-
Forbion raises €2.3bn in record life science fundraising
Dutch life science investor Forbion has raised 2.3 billion euros – capital that could provide funding for around 30 biotech companies.
-
Natural Cycles sharpens Nordic focus with new regional chief
After nearly a decade at Natural Cycles, Sofie Askervall has stepped into the newly created role of Head of Nordics. “Right now, we are looking closely at Norway,” she says.
-
Stryker CEO steps down – company veteran takes over
After more than 15 years at Stryker, Kevin Lobo will step down as CEO at the end of the year. He will be succeeded by Chief Operating Officer Spencer Stiles, who has spent almost his entire career at the US medtech giant.
-
Medivir’s second act: three drugs to enter Phase 2
As recently as last autumn, the situation was critical, with cash reserves dwindling and the share price falling. Today, Medivir is well funded, its ownership structure has been strengthened, and three fully funded Phase 2 programmes are moving forward.“We are in a strong position now,” says CEO Jens Lindberg.
-
AstraZeneca opens $1bn R&D centre in US
AstraZeneca has now opened its new research and development centre in Cambridge, Massachusetts – an investment of nearly 1 billion dollars.
-
Orexo seeks SEK 250 million to fund pipeline and DOJ settlement
Orexo had SEK 118.7 million in available cash at the end of August. The Uppsala-based company now wants to raise a further SEK 250 million to fund its development pipeline and the expected DOJ settlement.
-
Nobel discovery helps explain cause and effect in the brain
“Optogenetics is a revolutionary technique that allows us to study the brain in an entirely new way,” says Linda Engström Ruud, associate professor of physiology at the University of Gothenburg, whose research uses the technology recognised by this year’s Nobel Prize.
-
Novo's facility remediation delays haemophilia A drug
The FDA has informed Novo that the BLA review of the antibody denecimig for the treatment of haemophilia A is still ongoing with no new timeline.
-
Genmab scores Phase 3 win in blood cancer trial
Genmab and AbbVie report positive results from a late-stage study evaluating the bispecific antibody epcoritamab in the most common type of non-Hodgkin lymphoma.
-
Omnio raises €2.9m for chronic wound therapy
Swedish biotech company Omnio has secured €2.9 million from existing investors and shareholders. The funding will be used to advance its plasminogen-based biological therapy for chronic wounds into first-in-human clinical studies.
-
Russian lab worker’s death sparks suspected plague investigation
Russian authorities have placed around 200 people under medical observation amid suspicions of plague, following the death of a 28-year-old laboratory worker in the Irkutsk region.
-
Under-pressure CSL strikes billion-dollar deal – bets on new phase II candidate
Job cuts, a lowered earnings forecast and concerns over its vaccine business have put CSL under pressure. Now the Australian pharmaceutical giant is making a major bet on a Swiss drug candidate for rare kidney and liver diseases.
-
Discoveries in optogenetics awarded Nobel medicine prize
The 2026 Nobel Prize in Physiology or Medicine is awarded to Karl Deisseroth, Peter Hegemann and Georg Nagel “for their discoveries concerning light-gated ion channels and optogenetics.”
-
New AI model could reduce unnecessary surgery for women
Every misjudged ovarian abnormality costs time, money and unnecessary anxiety. A new AI model may offer a solution – once it is fully implemented into the patient pathway.
-
Alligator slims down as new CEO takes over
Alligator Bioscience has appointed Johan Giléus as its new CEO, succeeding Søren Bregenholt, who will leave the company at the end of the year.
-
Novartis strikes $7.8bn deal with Chinese biotech
Novartis has signed a multibillion-dollar licensing deal with Chinese biotech company Abogen in the field of autoimmune diseases.
BREAKING